Retatrutide Phase 3 Trial Results Show Massive Weight Loss

Biohackers Connect

Hacking the Human System

Tasia

·6 months ago

shared a media post in group #Biohackers Connect

Retatrutide phase 3 obesity trial just came out and the results are genuinely insane:

- 28.3% bodyweight lost on 12mg over 80 weeks
- 70.3 pounds on avg. or 31.9 kg
- 45.3% of patients hit 30%+ weight loss (this is bariatric surgery territory)
- 30.3% weight loss (85 lbs) at 104 weeks in higher-BMI patients
- 65.3% of 12mg patients dropped below the obesity BMI threshold
- 19% loss on 4mg over 80 weeks (47.2 lbs) with fewer dropouts than placebo (4.1% vs 4.9%)
- significant drops in blood pressure, triglycerides, non-HDL cholesterol, waist circumference, and hsCRP
- no cardiac or liver signals

Retatrutide is going to completely overshadow tirzepatide and semaglutide, and take the throne as the best-selling drug of all time.

https://x.com/maxmarchion.. 
#Healthspan Advocates

Retatrutide phase 3 obesity trial just came out and the results are genuinely insane:

- 28.3% bodyweight lost on 12mg over 8

Sam Mendoza
4 to 12mg comes with a lot of side effects that people aren’t discussing. Speaking from first hand experience - Random Paranoia and Anxiety episodes - Sleep disruption - Heart palpitations You have to titrate up for a long time beforehand to get to those doses. Proceed with caution guys

Todd Smith
I still want to know muscle loss / muscle preservation of Reta vereus Sema and Tirz

Nate
Inside tech’s feverish demand for retatrutide (theinformation.com/articl..), a supposed super peptide.
www.theinformation.com
Inside Tech’s Feverish Demand for Retatrutide, a Supposed Super Peptide
For more than a decade, Dr. Molly Maloof has had a front-row seat to Silicon Valley’s ever-evolving health obsessions as a physician and founder of M3 Healthspan, a San Francisco–based concierge medical practice serving the tech elite. Lately, those conversations have focused on one substance ...

Jerome Cody
Nate
Inside tech’s feverish demand for retatr...
Demand for knockoff versions of retatrutide, a peptide-based drug being developed by Eli Lilly, has skyrocketed lately, propelling a gray market that likely exceeds $100 million in annual sales, according to an estimate prepared by The Information that examined many of the market’s biggest suppliers. Retatrutide, or reta as it is commonly called, has become popular among the tech elite, who had already shown great interest in other peptide-based drugs. Reta is potentially far more potent, producing greater weight loss and possibly less muscle loss, but it hasn’t yet won approval from the FDA.

Embed post to a webpage :

<div data-postid="xkmkdpe" [...] </div>

Retatrutide Phase 3 Trial Results Show Massive Weight Loss

Tasia

Todd SmithI still want to know muscle loss / muscle preservation of Reta vereus Sema and Tirz

Todd Smith
I still want to know muscle loss / muscle preservation of Reta vereus Sema and Tirz